Community Contributor
Member since 2025
Views
30 Total number of views
Fair Values Set
0 Total number of fair values set
Comments
0 Total number of comments
Followers
0 Total number of followers

No bio added yet

No link added
MEM logo
Memphasys

Memphasys will witness revenue surge with promising growth

1) Catalysts — What Could Meaningfully Move Sales or Earnings? Regulatory & Commercial Milestones ✔ TGA Approval for Felix in Australia Memphasys recently received approval from the Therapeutic Goods Administration (TGA) in Australia for its Felix™ sperm separation system , enabling immediate commercial sales and deployment here — ahead of schedule.Read more

View narrative
30
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AU$0.00029
1.8k% overvalued intrinsic discount
Fair Value
Profit Margin
13.26%
Future PE
34.16x
Price in 2031
AU$0